Jorge Lagares-Garcia, MD
Colon & Rectal Surgery · Charleston, SCNPI 1609843135
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (25.3%), education and consulting fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Intuitive Surgical at 59.3% of the total. Reporting peaked in 2024 at $10,263 and has fallen 99.6% since, to $41 in 2025. Among colon & rectal surgery clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $236.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$14K
- Virtual Incision Corporation$6K
- Johnson & Johnson$2K
- Stryker$156
- TELA Bio, Inc.$134
- Reprise Biomedical, Inc.$126
- plus $650 from 13 others
What the payments were for
- Consulting fees$5,00022%
- Speaking & faculty fees$3,50015%
- Travel & lodging$5,80725%
- Food & beverage$3,05913%
- Education$5,25023%
- Gifts$3121%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 49 | $13,595 |
| Virtual Incision Corporation | 6 | $5,930 |
| Johnson & Johnson(2 entities) | 16 | $2,336 |
| Stryker | 1 | $156 |
| TELA Bio, Inc. | 1 | $134 |
| Reprise Biomedical, Inc. | 1 | $126 |
| Axonics, Inc. | 5 | $126 |
| AbbVie | 4 | $115 |
| KCI USA, Inc. | 1 | $109 |
| Braintree Laboratories, Inc. | 2 | $60 |
| Medtronic | 1 | $44 |
| Shire North American Group Inc | 2 | $43 |
| Convatec Inc. | 2 | $39 |
| Hollister Incorporated | 1 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
| Merck | 1 | $21 |
| Madrigal Pharmaceuticals | 1 | $21 |
| Cook Medical LLC | 1 | $12 |
| THD America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$9,636
- Mira!$5,875
- DA VINCI SP$3,000
- SPY-PHI SYSTEM$156
- Ovitex$134
- PREVENA$109
- VAC VERAFLO$109
- ECHELON ENDOPATH$109
How this compares
$22,928 in reported general payments places this provider in the 95th percentile of 35 colon & rectal surgery providers in South Carolina.
See all colon & rectal surgery providers in South Carolina →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 29 | $181 |
| Oxycodone Hcl | 33 | $87 |
| Neomycin Sulfate | 14 | $69 |
| Metronidazole | 16 | $31 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Charleston
- Thomas CurranCharleston$11K
- Pinckney MaxwellCharleston$882
- Cyrus FeizpourCharleston$419
- Dean AdamsGreenville$12K
- Sidney MorrisonColumbia$11K
- Susan KnocheSummerville$9K
- Gabriel ChedisterSummerville$6K
- Anna MatrachisiaSummerville$5K
- Katherine RosenColumbia$4K
- Melissa HiteGreenville$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.